RT Book, Section A1 Waters, John K. A1 Reznik, Scott I. A2 Grippi, Michael A. A2 Antin-Ozerkis, Danielle E. A2 Dela Cruz, Charles S. A2 Kotloff, Robert M. A2 Kotton, Camille Nelson A2 Pack, Allan I. SR Print(0) ID 1195013173 T1 Treatment of Non–Small-Cell Lung Cancer: Surgery T2 Fishman’s Pulmonary Diseases and Disorders, 6e YR 2023 FD 2023 PB McGraw-Hill Education PP New York, NY SN 9781260473988 LK accessmedicine.mhmedical.com/content.aspx?aid=1195013173 RD 2024/03/28 AB Lung cancer is the deadliest malignancy, accounting for more annual deaths than breast, prostate, and colorectal cancer combined. In 2018, 1.7 million people died worldwide from this disease, which accounts for 18.4% of all cancer deaths.1 In 2020, it will claim the lives of 135,0000 Americans.2 Lung cancer was a rare disease until the early part of the 20th century. In 1879, lung cancer represented only 1% of cancers identified at autopsy compared with 14% in 1927.3